BIOPHARMACEUTICAL

Advancing Innovation in Biopharmaceuticals with a Leading Global Biopharma Partner

January 19, 2026

Advancing Innovation in Biopharmaceuticals with a Leading Global Biopharma Partner

Actylis: Advancing Innovation in Biopharmaceuticals with a Leading Global Biopharma Partner

In the dynamic realm of biopharmaceuticals, Actylis stands out as a crucial collaborator, consistently offering forward-thinking solutions to address complex industry challenges. This series of case studies highlights Actylis’ strategic initiatives and their significant role in resolving critical manufacturing obstacles in the biopharma sector.

Transforming Concentrated Buffer Production for a Major Biopharma Client

Challenge: The client required 10× concentrated buffers, representing a substantial shift from their existing formulation, particularly with respect to pH parameters.

Actylis fine-tuned the formulation’s pH by precisely adding NaOH or HCl and closely monitoring levels throughout the process. The R&D phase was fast-tracked, resulting in a successful product launch within just six weeks.

Benefits: Partnering with Actylis enabled the client to refine their production process, meet strict specifications, and accelerate their market launch. The customized solution not only conserved resources but also strengthened the biopharma CDMO’s market position.

Resolving Bag Integrity Concerns for a Biopharma Supplier

Challenge: The biopharma supplier encountered issues with bag integrity due to defective welding, raising concerns regarding documentation and potential sterility breaches identified during visual inspection.

Actylis collaborated closely with the supplier, deploying QA specialists on-site to inspect the bags. Together, the teams prepared the necessary documentation to release the batches under comprehensive GMP oversight.

Benefits: By leveraging Actylis’ expertise and collaborative approach, the supplier successfully addressed the integrity issues while maintaining product quality and compliance. Actylis’ transparency and strict adherence to GMP standards helped build confidence and trust among stakeholders.

Preventing Sample Bag Shortages

Challenge: A global shortage of single-use bio bags, combined with increasing demand per commercial batch, placed pressure on supply timelines and production delivery.

Actylis responded by maintaining strategic buffer stock and placing advance orders for sample bags. Through proactive planning and strong partner networks, Actylis ensured production continued without disruption.

Benefits: Clients benefited from uninterrupted production and minimized delays. Actylis’ reliability and commitment to excellence strengthened client trust and reinforced long-term working relationships.

Navigating Raw Material Supply Constraints

Challenge: Surging demand and extended lead times for key raw materials such as Tris, HEPES, and NaOH created challenges in meeting production schedules.

To mitigate these risks, Actylis leveraged strong relationships with key suppliers and qualified alternate sources. The team also worked closely with clients to utilize safety stocks and, when required, enable direct procurement.

Benefits: Actylis’ proactive and forward-looking strategy minimized disruptions caused by raw material shortages, ensuring timely production and fulfilment of client needs. Transparent communication and strong supplier-client collaboration further strengthened supply chain resilience.

Looking Ahead

Actylis continues to transform the biopharmaceutical manufacturing landscape by enabling clients to overcome challenges and drive innovation forward. With a strong commitment to quality, compliance, and partnership, Actylis remains a trusted leader shaping the future of the biopharma industry.

Advancing Innovation in Biopharmaceuticals with a Leading Global Biopharma Partner

advancing-innovation-in-biopharmaceuticals-with-a-leading-global-biopharma-partner

⬆ Back to Top
BIOPHARMACEUTICAL

Recent Blogs

PHARMACEUTICAL

GLP-1 Formulation Solutions in India: Excipients for Oral and Injectable Peptide Therapies

August 21, 2026

GLP-1 formulation solutions in India include specialized pharmaceutical excipients, absorption enhancers, preservatives, buffers, high-purity solve...
Read Story
COSMETICS

Unlocking More from Trusted Actives with Smarter Skin Delivery

July 13, 2026

Some of today’s most successful hero molecules in personal care are not always easy to work with. Maybe that’s the nature of heroes – powerful but...
Read Story
PHARMACEUTICAL

Beyond the Solvent: Choosing a Supply Partner That Can Scale with Your Manufacturing

July 13, 2026

In pharmaceutical and specialty chemical manufacturing, solvents are often viewed as standard raw materials. However, as manufacturing processes be...
Read Story
SPECIALTY CHEMICALS

Improving Pigment Dispersion with Alkaline Additives

July 8, 2026

Effective pigment dispersion depends on three linked steps: wetting, deagglomeration, and stabilization; authoritative coatings guidance...
Read Story